Immuron Ltd
F:ANW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Immuron Ltd
F:ANW
|
AU |
|
D
|
DigitalOcean Holdings Inc
F:0SU
|
US |
|
Alan Allman Associates SA
PAR:AAA
|
FR |
|
Bravura Solutions Ltd
ASX:BVS
|
AU |
|
T
|
Telefonaktiebolaget LM Ericsson
XMUN:ERCB
|
SE |
|
P
|
Public Service Enterprise Group Inc
DUS:PSE
|
US |
|
Shanghai Electric Group Co Ltd
F:USR
|
CN |
|
Acciona SA
F:AJ3
|
ES |
|
B
|
Bravura Solutions Ltd
OTC:BVSFF
|
AU |
|
I
|
Imexpharm Corp
VN:IMP
|
VN |
|
F
|
Fielmann Group AG
XMUN:FIE
|
DE |
|
M
|
Mitsubishi Heavy Industries Ltd
XMUN:MIH
|
JP |
Intrinsic Value
Is ANW undervalued or overvalued?
See the intrinsic value estimate for 
Immuron Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ANW looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with ANW’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Immuron Does
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada.
- Headquarters
- Australia AU
- Employees
- 7
- IPO date
- Apr 30, 1999
Earnings Waterfall
Immuron Ltd
The intrinsic value for Immuron Ltd (ANW) under the Base Case is hidden EUR.
Compared with the current market price of 0.0155 EUR, the stock appears hidden.